SCHEMBL3602717

SCHEMBL3602717

CC(C)c1c[c]c(O)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 4/20 0.40
PTGS1 P23219 3/20 0.40
TRPA1 O75762 1/20 0.40
CACNA1C Q13936 1/20 0.40
HTT P42858 3/20 0.39
HIF1A Q16665 3/20 0.39
ALDH1A1 P00352 2/20 0.39
ALOX12 P18054 2/20 0.39
GAA P10253 1/20 0.39
ESR1 P03372 1/20 0.37
PDCD1 Q15116 1/20 0.37
ESR2 Q92731 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
RNASEH1 O60930 1/20 0.36
PTGS2 P35354 1/20 0.33
CYP2C9 P11712 3/20 0.32
KDM4E B2RXH2 2/20 0.32
CA1 P00915 2/20 0.32
CA2 P00918 2/20 0.32
CYP3A4 P08684 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11679214 0.77 ESR1 (0.39) ALDH1A1ESR1PDCD1ESR2CD274
SCHEMBL1492629 0.73 LMNA (0.38) TYRPTGS1TRPA1CACNA1CHTT
SCHEMBL1188027 0.73 TYR (0.34) TYRPTGS1TRPA1CACNA1CHTT
SCHEMBL17262605 0.71 TYR (0.33) TYRPTGS1TRPA1CACNA1CHTT
SCHEMBL191957 0.71 TYR (0.38) TYRHTTHIF1AALDH1A1CYP2C9
SCHEMBL2585466 0.71 TYR (0.33) TYRPTGS1TRPA1CACNA1CHTT
SCHEMBL6392171 0.69
SCHEMBL162301 0.68 ALDH1A1 (0.37) TYRALDH1A1CA1CA2HPGD
SCHEMBL7229461 0.68 GABRA1 (0.47) PTGS1TRPA1CACNA1CHTTHIF1A
SCHEMBL17203715 0.68 KMT2A (0.44) ALDH1A1GAAMAPTCYP2D6TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117285451-A Polysubstituted pyrrole compound and synthetic method and application thereof 重庆文理学院 2023-12-26 CN claimed
US-20120184583-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-19 US claimed
US-20100144798-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-06-10 US claimed
EP-1601657-A1 PYRAZOLE MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Vertex Pharmaceuticals Incorporated (US) 2005-12-07 EP claimed
US-20050113423-A1 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2005-05-26 US claimed
WO-2004080972-A1 PIRAZOLE MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-09-23 WO claimed
CN-117285451-A Polysubstituted pyrrole compound and synthetic method and application thereof 重庆文理学院 2023-12-26 CN disclosed
CN-114401952-A Substituted cycloalkyl compounds as modulators of integrated stress pathways 卡里科生命科学有限责任公司 2022-04-26 CN disclosed
US-20120184583-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-07-19 US disclosed
CN-1930006-B Developer mixture for thermal recording materials and thermal recording materials API CORP 2010-12-08 CN disclosed
US-20100144798-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-06-10 US disclosed
CN-1930006-A Developer mixture for thermal recording materials and thermal recording materials API CORP (JP) 2007-03-14 CN disclosed
EP-1601657-A1 PYRAZOLE MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS Vertex Pharmaceuticals Incorporated (US) 2005-12-07 EP disclosed
US-20050113423-A1 Modulators of ATP-binding cassette transporters VERTEX PHARMACEUTICALS INCORPORATED 2005-05-26 US disclosed
WO-2004080972-A1 PIRAZOLE MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2004-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120184583-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 TYR 4882/4885PTGS1 1613/4885TRPA1 1061/4885
US-20100144798-A1 Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 TYR 4882/4885PTGS1 1613/4885TRPA1 1061/4885
US-20050113423-A1 Modulators of ATP-binding cassette transporters CFTR, ABCB1, ABCC2 TYR 4882/4885PTGS1 1613/4885TRPA1 1061/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.